Association of Donor and Recipient Telomere Length with Clinical Outcomes Following Lung Transplantation
Overview
Authors
Affiliations
Background: Patients with short telomere syndromes and pulmonary fibrosis have increased complications after lung transplant. However, the more general impact of donor and recipient telomere length in lung transplant has not been well characterized.
Methods: This was an observational cohort study of patients who received lung transplant at a single center between January 1st 2012 and January 31st 2015. Relative donor lymphocyte telomere length was measured and classified into long (third tertile) and short (other tertiles). Relative recipient lung telomere length was measured and classified into short (first tertile) and long (other tertiles). Outcome data included survival, need for modification of immunosuppression, liver or kidney injury, cytomegalovirus reactivation, and acute rejection.
Results: Recipient lung tissue telomere lengths were measured for 54 of the 79 patients (68.3%) who underwent transplant during the study period. Donor lymphocyte telomeres were measured for 45 (83.3%) of these recipients. Neither long donor telomere length (hazard ratio [HR] = 0.58, 95% confidence interval [CI], 0.12-2.85, p = 0.50) nor short recipient telomere length (HR = 1.01, 95% CI = 0.50-2.05, p = 0.96) were associated with adjusted survival following lung transplant. Recipients with short telomeres were less likely to have acute cellular rejection (23.5% vs. 58.8%, p = 0.02) but were not more likely to have other organ dysfunction.
Conclusions: In this small cohort, neither long donor lymphocyte telomeres nor short recipient lung tissue telomeres were associated with adjusted survival after lung transplantation. Larger studies are needed to confirm these findings.
Dratwa-Kuzmin M, Lacina P, Wysoczanska B, Kilinska D, Siemaszko J, Sobczyk-Kruszelnicka M J Cancer Res Clin Oncol. 2025; 151(3):109.
PMID: 40082305 PMC: 11906511. DOI: 10.1007/s00432-025-06160-7.
Kapse B, Budev M, Singer J, Greenland J Front Transplant. 2024; 3:1356948.
PMID: 38993782 PMC: 11235310. DOI: 10.3389/frtra.2024.1356948.
Pennington K, Simonetto D, Taner T, Mangaonkar A Curr Hematol Malig Rep. 2024; 19(6):293-299.
PMID: 38315384 DOI: 10.1007/s11899-024-00724-z.
Molecular monitoring of lung allograft health: is it ready for routine clinical use?.
Pradere P, Zajacova A, Bos S, Le Pavec J, Fisher A Eur Respir Rev. 2023; 32(170).
PMID: 37993125 PMC: 10663940. DOI: 10.1183/16000617.0125-2023.
Greenland J, Guo R, Lee S, Tran L, Kapse B, Kukreja J J Heart Lung Transplant. 2023; 42(12):1700-1709.
PMID: 37648073 PMC: 10858720. DOI: 10.1016/j.healun.2023.08.018.